Mortality Data 'Inadvertently Omitted' From IN.PACT Analysis of Paclitaxel-Coated Balloons - TCTMD

Mortality Data 'Inadvertently Omitted' From IN.PACT Analysis of Paclitaxel-Coated Balloons  TCTMD

Amid the scramble by researchers and industry representatives to make sense of safety issues raised with paclitaxel-based balloons and stents for PAD, ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more